Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective

Patrick W. Serruys; Masafumi Ono; Scot Garg; Hironori Hara; Hideyuki Kawashima; Giulio Pompilio; Daniele Andreini; David R. Holmes; Yoshinobu Onuma; Spencer B. King

doi:10.1016/j.jacc.2021.05.024

Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective

Patrick W. Serruys, Masafumi Ono, Scot Garg, Hironori Hara, Hideyuki Kawashima, Giulio Pompilio, Daniele Andreini, David R. Holmes, Yoshinobu Onuma, Spencer B. King

Cardiovascular Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with advanced coronary artery disease. However, trialists have struggled to establish the respective roles for percutaneous coronary intervention and coronary artery bypass graft surgery, especially in patients with multivessel disease and unprotected left-main stem coronary artery disease. Several pivotal trials and meta-analyses comparing these 2 revascularization strategies have enabled the relative merits of each technique to be established with regard to the type of ischemic syndrome, the coronary anatomy, and the patient's overall comorbidity. Precision medicine with individualized prognosis is emerging as an important method of selecting treatment.

Original language	English (US)
Pages (from-to)	384-407
Number of pages	24
Journal	Journal of the American College of Cardiology
Volume	78
Issue number	4
DOIs	https://doi.org/10.1016/j.jacc.2021.05.024
State	Published - Jul 27 2021

Keywords

coronary artery bypass graft
coronary artery disease
drug-eluting stent
percutaneous coronary intervention

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jacc.2021.05.024

Cite this

@article{3d5f4285d4324a9d97281f6eb0cffb7f,

title = "Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective",

abstract = "Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with advanced coronary artery disease. However, trialists have struggled to establish the respective roles for percutaneous coronary intervention and coronary artery bypass graft surgery, especially in patients with multivessel disease and unprotected left-main stem coronary artery disease. Several pivotal trials and meta-analyses comparing these 2 revascularization strategies have enabled the relative merits of each technique to be established with regard to the type of ischemic syndrome, the coronary anatomy, and the patient's overall comorbidity. Precision medicine with individualized prognosis is emerging as an important method of selecting treatment.",

keywords = "coronary artery bypass graft, coronary artery disease, drug-eluting stent, percutaneous coronary intervention",

author = "Serruys, {Patrick W.} and Masafumi Ono and Scot Garg and Hironori Hara and Hideyuki Kawashima and Giulio Pompilio and Daniele Andreini and Holmes, {David R.} and Yoshinobu Onuma and King, {Spencer B.}",

note = "Publisher Copyright: {\textcopyright} 2021 American College of Cardiology Foundation",

year = "2021",

month = jul,

day = "27",

doi = "10.1016/j.jacc.2021.05.024",

language = "English (US)",

volume = "78",

pages = "384--407",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier USA",

number = "4",

}

TY - JOUR

T1 - Percutaneous Coronary Revascularization

T2 - JACC Historical Breakthroughs in Perspective

AU - Serruys, Patrick W.

AU - Ono, Masafumi

AU - Garg, Scot

AU - Hara, Hironori

AU - Kawashima, Hideyuki

AU - Pompilio, Giulio

AU - Andreini, Daniele

AU - Holmes, David R.

AU - Onuma, Yoshinobu

AU - King, Spencer B.

PY - 2021/7/27

Y1 - 2021/7/27

N2 - Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with advanced coronary artery disease. However, trialists have struggled to establish the respective roles for percutaneous coronary intervention and coronary artery bypass graft surgery, especially in patients with multivessel disease and unprotected left-main stem coronary artery disease. Several pivotal trials and meta-analyses comparing these 2 revascularization strategies have enabled the relative merits of each technique to be established with regard to the type of ischemic syndrome, the coronary anatomy, and the patient's overall comorbidity. Precision medicine with individualized prognosis is emerging as an important method of selecting treatment.

AB - Over the last 4 decades, percutaneous coronary intervention has evolved dramatically and is now an acceptable treatment option for patients with advanced coronary artery disease. However, trialists have struggled to establish the respective roles for percutaneous coronary intervention and coronary artery bypass graft surgery, especially in patients with multivessel disease and unprotected left-main stem coronary artery disease. Several pivotal trials and meta-analyses comparing these 2 revascularization strategies have enabled the relative merits of each technique to be established with regard to the type of ischemic syndrome, the coronary anatomy, and the patient's overall comorbidity. Precision medicine with individualized prognosis is emerging as an important method of selecting treatment.

KW - coronary artery bypass graft

KW - coronary artery disease

KW - drug-eluting stent

KW - percutaneous coronary intervention

UR - http://www.scopus.com/inward/record.url?scp=85109836462&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85109836462&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2021.05.024

DO - 10.1016/j.jacc.2021.05.024

M3 - Review article

C2 - 34294273

AN - SCOPUS:85109836462

SN - 0735-1097

VL - 78

SP - 384

EP - 407

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 4

ER -

Percutaneous Coronary Revascularization: JACC Historical Breakthroughs in Perspective

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this